Biopharma giant Bristol Myers Squibb (BMS) has invested $100 million in a new cutting edge facility in Hyderabad that will expand the company’s global drug...
Continue Reading
The researchers claim that ‘R+Cu’ can shield patients from the toxic effects of chemotherapy: PexelsIn a major discovery, scientists and doctors at Mumbai’s Tata Institute,...
Continue Reading
As part of an effort to ramp up its manufacturing footprint, Suven Pharmaceuticals plans to merge (PDF) with fellow India-based CDMO Cohance Lifesciences.Cohance is privately...
Continue Reading
As per the media reports, Morepen Laboratories in a press statement said that its board has approved to raise upto Rs 350 crore through the...
Continue Reading
Takeda and Biological E. Limited (BE) has announced a strategic partnership to accelerate access to QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs)....
Continue Reading
Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions...
Continue Reading
India will continue to protect the interests of its generic drug firms and has rejected European Free Trade Association (EFTA) nations’ demand to keep “data...
Continue Reading
Viatris announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimised Risk...
Continue Reading
The Central Drugs Standard Control Organisation (CDSCO) has issued new guidelines for effective surveillance for quality and efficacy of drugs and cosmetics available in the...
Continue Reading